Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This study was a single-center, randomized, controlled prospective study. Those who had
premature ovarian failure and who had fertility requirements were enrolled in the study. To
determine the efficacy and safety of umbilical cord mesenchymal stem cells in the treatment
of patients with POI.